Read how NIAID scientists are progressing toward a faster, more practical way to screen people and animals for prion diseases.
These forms are provided for reference only. Most agreements must be negotiated, approved, and signed by OTD. Please contact OTD for further information.
On this page:
Confidential Disclosure Agreement (CDA)
A CDA is used to ensure that a party receiving proprietary information (for example, unpublished data or know-how) will keep the information confidential for a certain period of time, usually three to five years.
Simple Letter Agreement (SLA)
An SLA is used to transfer materials between laboratories for non-commercial research purposes. An unmodified SLA may be signed by your branch chief. Modified SLAs must be signed by OTD.
Material Transfer Agreement (MTA)
An MTA is used to transfer materials between laboratories, generally for non-commercial research purposes.
Cooperative Research and Development Agreement (CRADA)
A CRADA defines the scope and terms of collaborative relationships between NIAID scientists and outside collaborators. The collaborator usually shares research, funding, and staffing costs. The CRADA is the only mechanism, other than an unsolicited gift, by which government laboratories may receive outside funds to support their research. NIAID/NIH owns patents on inventions that arise from its work conducted under a CRADA, but the collaborator obtains an option to negotiate an exclusive license to these inventions.
There are four types of CRADAs:
For sample CRADA forms, visit Forms & Model Agreements (NIH Web site).
back to top
Last Updated September 17, 2009